Cardio3 BioSciences To Raise Capital Via A Private Placement Of New Shares

Cardio3 BioSciences , a leader in the discovery and development of cell therapies, announces today the launch of a private placement of new ordinary shares to institutional investors. Cardio3 BioSciences intends to raise up to a maximum of 713,380 new shares .

http://ift.tt/1DuM3gH